Key facts
- Ultralight’s last known valuation is $35.0M (Jul 2025).
- It has raised $13.8M; the latest was Seed Round ($9.3M) in Jan 2026.
- Notable investors include Hustle Fund, Anthemis, Emerson Collective, Lombardstreet Ventures, The General Partnership — 11 tracked in total.
- Status: Privately Held (backing).
Leadership
- Pedro TabioChief Technology Officer & Founder
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Ultralight
- ·The full record, as it builds
Funding rounds
No funding rounds for Ultralight are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ultralight
Operator of a healthcare platform intended for personalized medicine practices. The company leverages artificial intelligence and tools like clinical co-pilot and patient app to automate manual processes, remove communication barriers, and craft a personalized experience that modern-day patients expect, enabling clinicians to elevate their practice while keeping the human touch at the heart of healthcare.
- Sector
- Healthcare
- HQ
- Mill Valley, CA, United States
- Founded
- 2024
- Employees
- 43
- Website
- ultralighthealth.com/
- Ownership
- Privately Held (backing)
Ultralight doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ultralight shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ultralight in its N-PORT filings yet. We sweep new filings monthly.